期刊文献+

XIAP和survivin联合检测判断乳腺癌预后的研究 被引量:2

Study of combined determination of XIAP and survivin for predicting the prognosis of breast carcinoma
暂未订购
导出
摘要 目的研究乳腺癌组织X染色体连锁的凋亡抑制蛋白(X IAP)和survivin基因变化规律,探讨两者预测乳腺癌复发的价值。方法应用免疫组织化学方法检测6 5例良、恶性乳腺病变组织中X IAP和survivin的表达,并比较其阳性表达率的差异。结果复发乳腺癌(复发组)两指标的阳性率依次为8 2.2%和8 5.7%,无复发乳腺癌组织(无复发组)依次为5 4.5%和4 5.5%;两组的X IAP和survivin阳性表达率均高于乳腺纤维腺瘤组织的2 0%和1 3.3%。复发组X IAP,survivin阳性表达明显高于无复发组(P<0.0 1)。复发组X IAP表达与组织学分级呈正相关(r=0.4 7 2,P<0.0 5),与激素受体呈负相关(r=-0.4 8 6,P<0.0 5);survivin表达与组织学分级亦呈正相关(r=0.5 3 2,P<0.0 5);X IAP表达与survivin表达呈正相关(r=0.4 4 7,P<0.0 5)。结论X IAP和survivin可能在乳腺癌的发生、发展过程中起重要作用。联合检测两指标可能更好地判断乳腺癌的预后。 Objective To study the expressions of XIAP and survivin in breast carcinoma tissues and their value in predicting the recurrence of breast carcinoma. Methods The expression of XIAP and survivin in 65 benign and 65 malignant breast paraffin-embedded specimens was detected by using immunohistochemical assay and the results were compared. Resuits The positive rate of XIAP and survivin in recurrent breast carcinoma (recurrent group ) was 82. 2 % and 85. 7 % respectively, and in non-recurrent breast carcinoma tissue ( non-recurrent group ) was 54.5 % and 45.5 % respectively, and in both groups were increased significantly as compared with that of benign breast tissues( 20.0% , and 13.3% respectively). The positive expression of XIAP and survivin was increased significantly in recurrent group as compared with non-recurrent group ( P 〈 0.01 ). In recurrent group, XIAP expression had a positive correlation with histologic grade ( r = 0.472, P 〈 0.05 ) , but negative correlation to estrogen and progesterone receptors ( r = - 0. 486, P 〈 0.05 ) ; survivin expression also had a positive correlation with histologic grade( r = 0. 532, P 〈0. 05 ) ;MAP and surviving expression had positive correlation ( r = 0. 447, P 〈 0. 05 ). Conclusions XIAP and survivin oncogene may play an important role in the development of breast cancer, and suggests that their combined detection is valuable for better prediction of the prognosis of breast cancer.
机构地区 沈阳军区第二
出处 《中国普通外科杂志》 CAS CSCD 2006年第4期253-256,共4页 China Journal of General Surgery
关键词 乳腺肿瘤 诊断 腺癌 预后 凋亡抑制蛋白 SURVIVIN Breast Neoplasms/diag Adenocarcinoma/diag Prognosis XIAP Survivin
  • 相关文献

参考文献10

  • 1Peter L,Natalle R,Katsuyukl T,et al.Suppression of apoptosis in mammalian cells by NAPI and a related family of IAP genes[J].Nature,1996,379(15):349 -353.
  • 2Ramp V,Krieg T,Caliskan E,et al.XIAP expression in an independent prognostic marker in clear-cell renal carcinomas[J].Hum Pathol,2004,35(8):1022-1028.
  • 3Gruslin A,Qiu Q,Tsang BK.Influence of maternal smoking on trophoblast apoptosis throughout development:possible involvement of XIAP regulation[J].Biol Reprod,2001,65 (4):1164 -1169.
  • 4Yang L,Cao Z,Yan H,et al.Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells:implication for cancer specific therapy[J].Cancer Res,2003,63(20):6815 -6824.
  • 5Li J,Feng Q,Kim JM,et al.Human ovarian cancer and cisplatin resistance possible role of inhibitor of apoptosis proteins[J].Endocrinology,2001,142(1):370 -380.
  • 6Rohayem J,Diestelkoetter P,Weigle B,et al.Antibody response to the tumor associated inhibitor of apoptosis protein surviving in cancer patients[J].Cancer Res,2000,60 (7):1815-1817.
  • 7Verhagen AM,Ekort PG,Pakusch M,et al.Identification of DIABLO a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins[J].Cell,2000,102 (1):43 -53.
  • 8Kobayashi K,Hatano M,Otaki M,et al.Expression of amurine homologue of the inhibitor of apoptosis protein is related to cell proliferation[J].Proe Natl Acad Sci USA,1999,96 (4):1457-1462.
  • 9李志红,王志明,穆拉德.三氧化二砷与阿霉素对人肝癌细胞株HepG2中survivin表达的影响[J].中国普通外科杂志,2005,14(6):441-447. 被引量:11
  • 10毛杰,海健,舒衡平,唐利立,申正堂,邬玉辉,欧慧英.乳腺癌组织中survivin,p53蛋白的表达与预后的关系[J].中国普通外科杂志,2005,14(4):265-268. 被引量:25

二级参考文献22

  • 1吴万敏,王小娟,孟化.survivin在乳腺癌中的表达及其临床意义[J].中国普通外科杂志,2004,13(11):868-869. 被引量:15
  • 2Ferreira CG, Epping M, Kruyt FA, et al. Apoptosis: target of cancer therapy[J].Clin Cancer Res, 2002, 8(7): 2024-2034.
  • 3Krammer PH. CD95's deadly mission in the immune system[J]. Nature, 2000, 407(6805): 789-795.
  • 4Wang X. The expanding role of mitochondria in apoptosis[J]. Genes Dev, 2001, 15(22): 2922-2933.
  • 5Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade[J]. Cell, 1997, 91(4): 479-489.
  • 6Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition[J]. Cell, 2000,102(1): 33- 42.
  • 7Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia[J]. Biochem Pharmacol, 1990, 40(10): 2353-2362.
  • 8Thompson CB. Apoptosis in the pathogenesis and treatment of disease[J]. Science, 1995, 267(5203): 1456-1462.
  • 9Hannun YA. Apoptosis and the dilemma of cancer chemotherapy[J]. Blood, 1997, 89(6): 1845-1853.
  • 10RolandT SkeelMD 于世英主译.癌症化疗手册[M].北京: 科学出版社,2002.281-283.

共引文献34

同被引文献13

  • 1王翔,高文信.XIAP与肿瘤关系的研究进展[J].口腔医学研究,2005,21(3):338-340. 被引量:4
  • 2Spee B,Junkers MD,Arends B,et al.Specific down regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin[J].Mol Cancer,2006,5(5):34.
  • 3Lee HJ,Lee HJ,Lee EO.Mitochondria-cytochrome C-Caspase-9 cascade mediates isorhamnetin-induced apoptosis[J].Cancer Lett,2008,270(2):342-353.
  • 4Silke J,Kratina T,Chu D,et al.Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis(IAP)protein abundance[J].Proc Natl Acad Sci USA,2005,102(45):16182-16187.
  • 5Lemaire C,Godefroy N,Costina-Parvu 1,et al.Caspase-9 can antagonize p53-induced apoptosis by generating a p76(Rb)truncated form of Rb[J].Oncogene,2005,24(20):3297-308.
  • 6Tamm I,Komblau SM,Segall H,et al.Expression and prognostic significance of IAP-family genes in human cancer and myeloid leukemias[J].Clin Cancer Res,2000,6(5):1 796-1 803.
  • 7Xu Y,Shen ZZ,Wiper D,et al.Lysophospfatidic acid as a potiential biomarker for ovarian and other gynecologic cancer[J].JAMA,1998,280:719-723.
  • 8Kobayashi K,Hatano M,Otaki M,et al.Express of amurine homologue of the inhibitor of apoptosis protein is related to cell proliferation[J].Proe Natl Acad Sci USA,1999,96(4):1 457-1 462.
  • 9Pustilnik TB,Estrella V,Wiener JR,et al.Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells[J].Clin Cancer Res,1999,5(11):3 704-3 710.
  • 10Skates SJ,Menonll,MacDonald N,et al.Calculation of the risk of ovarian cancer from serial CA125 values for preclinical detection in postmenopausal women[J].Clin Oncol,2003,21(10 Suppl):206-210.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部